More than 7 million Americans have Alzheimer’s Disease, according to the Alzheimer’s Association. And one in nine people over ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten with a federal deadline to halt off-brand products.

Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...

Roche, along with Bristol Myers Squibb, Novo Nordisk, AbbVie, Eli Lilly and others, is making inroads into molecular glues to ...

Many videos on the social media platform TikTok that are focused on obsessive thoughts about food include patient ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

A research team at Mount Sinai have developed a risk score they found accurate in predicting Crohn’s disease in patients ...

BioSpace examines the busiest corporate venture capital arms in the pharmaceutical industry. Novo Holdings, which made ...

Lilly employees log over 1 million hours of volunteer time during global service initiative, benefiting communities in Indiana.

As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing ...